ASXC TransEnterix Profit After Tax

Corporate emblem and logo of Asensus Surgical, Inc. (ASXC)

Asensus Surgical, Inc. (ASXC) is modernizing laparoscopy through AI and Senhance haptic feedback. The company's net profit margin on this chart reflects revenue dynamics, where the indicator remains at -0.08. Stable earnings are supported by the diversification of chip supplies and streamlined robot logistics. This success is further bolstered by the loyalty of a staff comprising leading engineers and medical software developers.

Net Income: Asensus Surgical (ASXC) for 07/04/2022 - 08/31/2024

Financial and market metric breakdowns for asensus.com (ASXC)

- market value and analyst target forecast:
Stock Price Asensus Surgical|ASXC - Price Target Chart
- market capitalization data:
Market Valuation ASXC|ASXC - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Asensus Surgical|ASXC - Company Net Assets|Market Capitalization to Book Value Ratio asensus.com|ASXC - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital Asensus Surgical, Inc.|ASXC - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Asensus Surgical|ASXC - Company Aggregate Debts|Debt to Book Value ASXC|ASXC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Asensus Surgical|Quick Liquidity Indicator asensus.com
- company profitability and valuation multiples indicators:
ASXC - Net Profit
Fundamental valuation:ASXC, TransEnterix
Flagship merchandise of TransEnterix

This indicator tracks the daily net profit of Asensus Surgical, Inc. (ASXC), enabling real-time monitoring of revenue volatility and eliminating information lags during fundamental valuation. Monitoring this financial success metric is critical for portfolio stress testing, as any sharp fluctuations in the curve may signal electronics logistics failures or challenges with international robot certification.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit CONMED Inc. CNMD|PLSE: Net Income|inmodemd.com - Profit After Payment of Taxes|PMI: Net Profit|SRDX - Net Financial Result|SENS (Senseonics Holdings) - Net Profit|Net Income NeuroPace Medical (NPCE)|Net Income TCMD (Tactile Systems Technology)|SNWV (sanuwave.com) - Final Profit|Company Net Income Outset Medical OM|ELMD - Net Income|LENSAR, Inc - Net Profit|Company Net Income AVITA Medical Inc|PROF: Net Profit|Company Profit BDMD|EDAP (EDAP TMS SA) - Net Profit|Bovie Medical (APYX) - Net Financial Result|Net Profit ICCM|Net Income pulmonx.com LUNG|Net Profit TELA (TELA Bio)|Net Profit CytoSorbents Corp CTSO|SRTS - Company Net Income|ZYXI: Company Net Income|ECOR (electrocore.com) - Net Income|Vicarious Surgical - Final Profit|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Net Profit|Company Net Income seastarmedical.com ICU|Company Net Income IRIDEX Corporation (IRIX)|ibs.inc (INBS) - Annual Net Income|Beyond Air - Net Income|Net Profit Profusa, Inc PFSA|STRATA Skin - Net Profit|Net Financial Result GlucoTrack Inc. GCTK|NanoVibronix, Inc. (NAOV) - Company Net Income|Profit After Tax VERO (Venus Concept Inc)|Company Net Income CHF Solutions|Net Income Aethlon Medical Corp (AEMD)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS: Net Profit|silkroadmed.com (SILK) - Net Profit